Green Signal Biopharma Private Limited
Quick facts
Phase 3 pipeline
- BCG Vaccine IP - Serum Institute of India · Immunology / Infectious Disease
BCG vaccine stimulates the immune system to recognize and attack tuberculosis-causing bacteria through activation of T-cells and macrophages.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Green Signal Biopharma Private Limited portfolio CI brief
- Green Signal Biopharma Private Limited pipeline updates RSS
Frequently asked questions about Green Signal Biopharma Private Limited
What is Green Signal Biopharma Private Limited's pipeline?
Green Signal Biopharma Private Limited has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include BCG Vaccine IP - Serum Institute of India.
Related
- Sector hub: All tracked pharma companies